Pembrolizumab And Lenvatinib In Leptomeningeal Metastases

NCT04729348 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
10
Enrollment
OTHER
Sponsor class

Stopped Planned interim analysis

Conditions

Interventions

Sponsor

Massachusetts General Hospital

Collaborators